Aimei Health Technology Co. Ltd. has extended the deadline to complete its initial business combination by one month, from January 6, 2026 to February 6, 2026, through a new financing arrangement. The company deposited $34,330.96 into its trust account, funded by an unsecured promissory note issued to its sponsor, Aimei Health Ltd., and United Hydrogen Group Inc., each of which contributed $17,165.48. The promissory note, which carries no interest, is due upon the completion of the proposed business combination with United Hydrogen. The lenders have the option to convert the loan into private units of Aimei Health Technology at a price of $10.00 per unit prior to the business combination. This marks the fourteenth extension permitted under Aimei Health Technology’s current articles of association.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aimei Health Technology Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-000589), on January 06, 2026, and is solely responsible for the information contained therein.